Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 463 entries
View as:

A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03398967 Org: User:
Start: 01/02/18 End: 05/20/22 Due: 05/20/23

Plan for Microwave Thermal Field

Phase: N/A Priority: Normal
NCT ID: NCT05270642 Org: User:
Start: 10/01/21 End: 12/30/22 Due: 12/30/23

A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT03991559 Org: User:
Start: 11/01/18 End: 05/31/20 Due: 05/31/21

Stroke Mechanism Evolution in Intracranial Atherosclerotic Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT02705599 Org: User:
Start: 08/31/14 End: 12/31/20 Due: 12/31/21

Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT01504971 Org: User:
Start: 01/31/11 End: 12/31/16 Due: 12/31/17

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05896046 Org: User:
Start: 06/14/23 End: 06/01/26 Due: 06/01/27

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02135822 Org: User:
Start: 05/31/14 End: 12/31/15 Due: 12/31/16

Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Phase: N/A Priority: Normal
NCT ID: NCT06713031 Org: User:
Start: 12/10/24 End: 10/31/26 Due: 10/31/27

Urinary Proteomics Analysis for Sepsis and Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT01493492 Org: User:
Start: 05/31/10 End: 01/31/12 Due: 01/31/13

Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06231160 Org: User:
Start: 02/01/24 End: 12/31/25 Due: 12/31/26

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01661790 Org: User:
Start: 08/31/09 End: 10/31/12 Due: 10/31/13

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT07008885 Org: User:
Start: 06/20/25 End: 05/31/27 Due: 05/31/28

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT07009002 Org: User:
Start: 06/20/25 End: 05/31/27 Due: 05/31/28

TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT05631912 Org: User:
Start: 06/30/23 End: 12/15/25 Due: 12/15/26

T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT02250209 Org: User:
Start: 07/31/14 End: 12/31/17 Due: 12/31/18

Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03115814 Org: User:
Start: 04/17/17 End: 06/30/19 Due: 06/30/20

GLP-1 on Non-ST-Segment Elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT02577848 Org: User:
Start: 10/31/15 End: 10/31/16 Due: 10/31/17

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03771222 Org: User:
Start: 01/31/19 End: 12/31/21 Due: 12/31/22

CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02259556 Org: User:
Start: 10/31/14 End: 10/31/29 Due: 10/31/30

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Phase: N/A Priority: Normal
NCT ID: NCT04915287 Org: User:
Start: 06/06/21 End: 07/31/23 Due: 07/31/24

MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound

Phase: N/A Priority: Normal
NCT ID: NCT02669199 Org: User:
Start: 01/31/12 End: 12/31/15 Due: 12/31/16

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04582604 Org: User:
Start: 09/01/20 End: 09/30/25 Due: 09/30/26

The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01802983 Org: User:
Start: 01/31/09 End: 12/31/13 Due: 12/31/14

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

Phase: N/A Priority: Normal
NCT ID: NCT02721940 Org: User:
Start: 02/29/12 End: 05/31/16 Due: 05/31/17

Clopidogrel Pharmacogenetic Score System

Phase: N/A Priority: Normal
NCT ID: NCT01990989 Org: User:
Start: 01/31/14 End: 01/31/15 Due: 01/31/16